Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,282,321
- Total 13F shares
- 43,564,795
- Share change
- +3,098,029
- Total reported value
- $2,238,109,644
- Put/Call ratio
- 38%
- Price per share
- $51.37
- Number of holders
- 191
- Value change
- +$155,550,097
- Number of buys
- 98
- Number of sells
- 105
Report period
Q1 2025
Institutions
191
Top holders
10
TARS full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
3,538,845
|
$195,945,847 | — | 31 Dec 2024 | |
| Cowen Financial Products LLC |
13D/G
|
— |
4.9%
|
1,909,228
|
$94,926,816 | $0 | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
1,969,071
|
$109,027,500 | — | 31 Dec 2024 | |
| RTW INVESTMENTS, LP |
13F
3/4/5
|
Company · 10%+ Owner |
7.7%
|
3,236,549
|
$179,207,718 | — | 31 Dec 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
6%
|
2,531,896
|
$140,191,082 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
5.9%
|
2,500,132
|
$138,432,310 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.3%
|
2,254,797
|
$124,848,110 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,115,162
|
$117,116,520 | — | 31 Dec 2024 | |
| TORONTO DOMINION BANK |
13F
|
Company |
4.5%
|
1,909,228
|
$105,713,954 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.8%
|
1,587,527
|
$87,901,370 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
3%
|
1,279,987
|
$70,873,000 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.7%
|
1,146,812
|
$63,498,980 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
2.2%
|
932,115
|
$51,611,206 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
916,856
|
$50,766,317 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
838,804
|
$46,455,645 | — | 31 Dec 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.9%
|
815,912
|
$45,177,000 | — | 31 Dec 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.6%
|
691,299
|
$38,277,226 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
644,010
|
$35,658,834 | — | 31 Dec 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.4%
|
607,689
|
$33,647,740 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.3%
|
570,056
|
$31,564,000 | — | 31 Dec 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.2%
|
500,000
|
$27,685,000 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
460,773
|
$25,514,000 | — | 31 Dec 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1%
|
420,758
|
$23,297,370 | — | 31 Dec 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.96%
|
404,237
|
$22,382,603 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.86%
|
365,544
|
$20,240,171 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
357,616
|
$19,801,198 | — | 31 Dec 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.83%
|
350,000
|
$19,379,500 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.81%
|
341,305
|
$18,897,208 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.8%
|
337,856
|
$18,707,086 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.75%
|
318,730
|
$17,648,080 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
293,700
|
$16,262,169 | — | 31 Dec 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
0.53%
|
224,713
|
$12,442,359 | — | 31 Dec 2024 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.47%
|
200,000
|
$11,074,000 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.44%
|
186,662
|
$10,335,475 | — | 31 Dec 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.43%
|
181,122
|
$10,028,725 | — | 31 Dec 2024 | |
| Atika Capital Management LLC |
13F
|
Company |
0.42%
|
177,200
|
$9,811,564 | — | 31 Dec 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.41%
|
173,144
|
$9,586,983 | — | 31 Dec 2024 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.4%
|
170,000
|
$9,412,900 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
156,403
|
$8,660,034 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.36%
|
153,441
|
$8,496,029 | — | 31 Dec 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.35%
|
148,735
|
$8,235,457 | — | 31 Dec 2024 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.34%
|
142,419
|
$7,885,740 | — | 31 Dec 2024 | |
| Principia Wealth Advisory, LLC |
13F
|
Company |
0.33%
|
138,445
|
$7,665,700 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.32%
|
136,795
|
$7,574,340 | — | 31 Dec 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
0.31%
|
130,195
|
$7,208,897 | — | 31 Dec 2024 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.31%
|
130,097
|
$7,203,471 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
129,184
|
$7,152,918 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.3%
|
125,539
|
$6,951,095 | — | 31 Dec 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.27%
|
112,500
|
$6,229,125 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.26%
|
110,889
|
$6,139,924 | — | 31 Dec 2024 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q1 2025
As of 31 Mar 2025,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,564,795 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock, Inc., Paradigm Biocapital Advisors LP, JENNISON ASSOCIATES LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, TORONTO DOMINION BANK, Deep Track Capital, LP, and Frazier Life Sciences Management, L.P..
This page lists
194
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
192
Q1 2025 holders
191
Holder diff
-1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.